David Kirn is co-founder and CEO of 4D Molecular Therapeutics (4DMT), a company using directed evolution to invent new adeno-associated virus (AAV) vectors that are tailored to specific target ...

the team's directed evolution process could reduce this timeline to just months or even weeks. "Our hope is that this method will accelerate the pipeline for mRNA therapeutics and vaccines ...

The following is a summary of “Modeling COVID-19 dynamics in the Basque Country: characterizing population immunity profile from 2020 to 2022,” published in the January 2025 issue of Infectious ...

President Joe Biden on April 6 directed that states make every adult eligible for a coronavirus vaccine by April 19, nearly two weeks earlier than his original directive, which was set for May 1.